Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Oncolytics Biotech Inc. (ONCY) had Stock-Based Compensation of $0.84M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.66M |
|
-- |
|
-- |
|
$4.87M |
|
$-4.87M |
|
$0.22M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.87M |
|
$-4.81M |
|
84.63M |
|
84.63M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$12.87M |
|
$0.27M |
|
$0.85M |
|
$13.72M |
|
$4.02M |
|
-- |
|
$5.18M |
|
$9.20M |
|
$4.52M |
|
$4.52M |
|
$4.52M |
|
86.42M |
|
| Cash Flow Statement Financials | |
$-4.53M |
|
-- |
|
$4.10M |
|
$11.10M |
|
$10.66M |
|
$-0.45M |
|
|
Stock-Based Compensation |
$0.84M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-102.97% |
|
-102.97% |
|
-33.94% |
|
-102.97% |
|
$0.05 |
|
$-0.05 |
|
$-0.05 |
|